Description
COVID-19 Neutralizing Antibody Test
The SARS-CoV-2 Neutralizing Antibody Test (Immunofluorescence Assay) is designed for the quantitative detection of neutralizing antibodies in human serum, plasma, venous whole blood, or fingertip blood. It is suitable for use with Getein fluorescence analyzers.
Evaluate Immune Response Post-Vaccination
This test identifies the presence and concentration of antibodies that block the SARS-CoV-2 virus from binding to human cells. It is ideal for assessing vaccine effectiveness or prior infection immune response—not for acute infection diagnosis.
Specifications
| Test Item | Sample | Volume | Method | Range | Time | Storage | Shelf Life |
|---|---|---|---|---|---|---|---|
| Neutralizing Antibody | Serum / Plasma / WB / Fingerstick | 40 μL | Immunofluorescence | 0.5–1000.0 BAU/mL | 15 min | 4–30°C | 24 months |
Compatible Devices
- Getein1100
- Getein1160
- Getein1180
- Getein1600
Clinical Use
- Assesses immune response post-vaccination or prior infection
- Not intended for acute COVID-19 diagnosis
- For in vitro diagnostic use by professionals only
